[CYCC] YoY Quarter Result on 30-Jun-2009 [#Q2]

Stock
[CYCC] Cyclacel Pharmaceuticals, Inc.
Announcement Date
13-Aug-2009
Financial Year
2009
Quarter
30-Jun-2009 [#Q2]
Profit Trend
QoQ- -39.15%
YoY- 17.54%
Quarter Report
CYCC's Result
CYCC's Financial Summary
View:
Show?
Quarter Result
30/06/12 30/06/11 30/06/10 30/06/09 30/06/08 30/06/07 30/06/06 CAGR
Revenue 146 168 119 266 180 31 36 26.25%
PBT -3,704 -3,678 -4,163 -7,278 -8,969 -4,158 -7,638 -11.35%
Tax -127 -126 -230 -233 -425 -563 -696 -24.66%
NP -3,577 -3,552 -3,933 -7,045 -8,544 -3,595 -6,942 -10.45%
Tax Rate - - - - - - - -
Total Cost 3,723 3,720 4,052 7,311 8,724 3,626 6,978 -9.93%
Ratio Analysis
30/06/12 30/06/11 30/06/10 30/06/09 30/06/08 30/06/07 30/06/06 CAGR
NP Margin -2,450.00 -2,114.29 -3,305.04 -2,648.50 -4,746.67 -11,596.77 -19,283.33 -29.07%
Per Share
30/06/12 30/06/11 30/06/10 30/06/09 30/06/08 30/06/07 30/06/06 CAGR
EPS -101.86 -128.11 -180.70 -579.26 -702.52 -295.93 -814.41 -29.26%
EPS Diluted -101.86 -128.11 -180.70 -579.26 -702.52 -295.93 -814.41 -29.26%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.